Home ›
Trademark Categories ›
Pharmaceuticals ›
2021 ›
OR ›
ORYZA HEALTHY
Trademark search for:
ORYZA HEALTHY
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2021-08-26 — Application filed
2021-08-30 — Application filed
2021-10-06 — Application filed
2022-05-31 — Assigned to examiner
2022-06-03 — Final disposition recorded
2022-06-03 — Final disposition recorded
2022-06-03 — Final disposition recorded
2022-11-16 — Office action issued
2022-11-16 — Correspondence received in law office
2022-11-17 — Teas/email correspondence entered
2023-01-12 — Final disposition recorded
2023-01-12 — Final disposition recorded
2023-01-12 — Final disposition recorded
2023-04-12 — Application filed
2023-04-12 — Application filed
2023-07-12 — Office action issued
2023-07-12 — Correspondence received in law office
2023-07-13 — Teas/email correspondence entered
2023-08-10 — Office action issued
2023-08-10 — Office action issued
2023-08-10 — Office action issued
2023-11-09 — Application filed
2023-11-09 — Application filed
2024-02-09 — Exparte appeal received at ttab
2024-02-09 — Jurisdiction restored to examining attorney
2024-02-09 — Ex parte appeal-instituted
2024-02-09 — Teas request for reconsideration received
2024-06-11 — Final disposition recorded
2024-06-11 — Action denying req for recon e-mailed
2024-06-11 — Notification of action denying req for recon e-mailed
2024-12-12 — Jurisdiction restored to examining attorney
2025-02-07 — Notification of examiners statement e-mailed
2025-02-07 — Examiners statement - completed
2025-02-07 — Examiners statement e-mailed
2025-03-03 — Reply brief filed - check ttab files
2025-04-14 — Office action issued
2025-07-14 — Application abandoned
2025-07-14 — Exparte appeal terminated
2025-07-14 — Final status recorded
2025-07-21 — Application abandoned
Owner Information
Oryza Pharmaceuticals, Inc.
Correspondent
E. ANTHONY FIGG ROTHWELL, FIGG, ERNST & MANBECK, PC
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
